A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis - Shefner, J M; Wolff, A A; Meng, L (Amyotroph Lateral Scler Frontotemporal Degener, 2016)
(5-6):